Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trialsEric L. Simpson, Kristian Reich, Amy M. DeLozier et al.|British Journal of Dermatology|2020Cited by 377
The effect of environmental humidity and temperature on skin barrier function and dermatitisKristiane A. Engebretsen, Jacob P. Thyssen|Journal of the European Academy of Dermatology and Venereology|2015Cited by 333
Association Between Topical Corticosteroid Use and Type 2 Diabetes in Two European Population-Based Adult CohortsY.M.F. Andersen, Jacob P. Thyssen, Alexander Egeberg et al.|Diabetes Care|2019Cited by 52
IL-9 sensitizes human TH2 cells to proinflammatory IL-18 signals in atopic dermatitisStefanie Schärli, Christoph Schlapbach, Fabian Luther et al.|Journal of Allergy and Clinical Immunology|2024Cited by 16
065 IL-18 activates human Th2 cells in atopic dermatitisStefanie Schärli, Christoph Schlapbach, Fabian Luther et al.|Journal of Investigative Dermatology|2024Cited by 0